Bristol Myers Squibb and Hengrui Pharma collaborated to jointly develop 13 early-stage programmes across oncology, haematology and immunology, with a potential deal value of up to USD 15.2 billion.
Strategic Collaboration | 13/05/2026 | By News Bureau
Mabtech, Sai Life Sciences Partner to Expand Advanced Immunology Services in the U.S.
Mabtech and Sai Life Sciences collaborate to deploy EYRA multiplex platform in Boston, enhancing access to advanced immune profiling for biopharma and biotech research.
Strategic Collaboration | 19/03/2026 | By News Bureau | 158
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy